ABBOTT INDIA LTD.

Abbott India Limited has announced the closure of its trading window for designated persons and their immediate relatives. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be closed effective Wednesday, July 1, 2026, and will reopen 48 hours after the declaration of the company's unaudited financial results for the quarter ending June 30, 2026. This is a standard regulatory procedure to prevent potential insider trading during sensitive financial reporting periods.

Abbott India has issued a communication to its shareholders regarding Tax Deduction at Source (TDS) on dividends. The company will deduct TDS at prescribed rates based on shareholder status and PAN verification, as per the Income Tax Act, 2025. Shareholders are urged to update their PAN, bank details, and residential status by July 24, 2026, to comply with TDS provisions. The recommended final dividend is INR 525 and special dividend is INR 131 per share, subject to AGM approval.

Abbott India Ltd. has appointed Ms. Swati Pathak as Associate Director - Operations, effective June 1, 2026. This appointment follows the recommendation of the Nomination and Remuneration Committee and approval by the Board of Directors. Ms. Pathak will be part of the Senior Management team. She brings over 22 years of experience, most recently leading the NPI & TAS function for Abbott’s Specialty Care business in India. She is not related to any Director/ Key Managerial Personnel/ Senior Management of the Company.

Abbott India Ltd has announced its audited financial results for the quarter and year ended March 31, 2026. The results, approved by the Board of Directors on May 11, 2026, show a revenue from operations of ₹6,929.05 Cr and a profit after tax of ₹1,552.02 Cr for the year ended March 31, 2026. The auditor's report, issued by M/s. Walker Chandiok & Co. LLP, has an unmodified opinion. The Board Meeting, where the results were approved, commenced at 6.00 pm and concluded at 7.30 pm.

Abbott India Ltd has fixed Friday, July 24, 2026, as the record date for determining members' entitlement to the final dividend for the financial year ended March 31, 2026. The dividend, if approved at the Annual General Meeting, will be paid on or after Tuesday, August 18, 2026, to members whose names appear on the Register of Members and Beneficial Owners as of the record date.

Abbott India Ltd's board approved the audited financial results for the year ended March 31, 2026. The company reported revenue from operations of ₹6,929.05 Mn and a profit before tax of ₹2,079.27 Mn. A final dividend of ₹525 and a special dividend of ₹131 per equity share were recommended, subject to shareholder approval. The AGM is scheduled for August 13, 2026, and the record date for the dividend is July 24, 2026, with payment on or after August 18, 2026.

Abbott India Ltd has scheduled a Board of Directors meeting on May 11, 2026, to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026. The board will also consider approving the audited financial statements for the same period and recommend a final dividend. The trading window remains closed from April 1, 2026, to May 13, 2026.

Abbott India Ltd's board meeting on April 22, 2026, addressed key management changes. Ms. Anisha Motwani's term as Independent Director ends on April 24, 2026. Mr. Neeraj Jain is appointed as an Additional Independent Director effective April 25, 2026, subject to member approval. Ms. Alison Davies resigned as Director effective April 22, 2026. Mr. James Wenner is appointed as Additional Non-Executive Director effective April 23, 2026, subject to member approval. Mr. Tushar Singh will transition to another Abbott affiliate on June 1, 2026, ceasing to be Senior Management Personnel on May 31, 2026. Mr. Amol Metkar is appointed as Plant Director - Goa and Senior Management Personnel effective June 1, 2026. The board also approved a postal ballot for the appointment of Mr. Jain and Mr. Wenner.

Abbott India Ltd's board meeting on April 22, 2026, addressed key management changes. Ms. Anisha Motwani's term as Independent Director ends on April 24, 2026. Mr. Neeraj Jain is appointed as an Additional Independent Director effective April 25, 2026, subject to member approval. Ms. Alison Davies resigned as Director effective April 22, 2026. Mr. James Wenner is appointed as Additional Non-Executive Director effective April 23, 2026, subject to member approval. Mr. Tushar Singh will transition to another Abbott affiliate on June 1, 2026, and Mr. Amol Metkar is appointed as Plant Director - Goa, effective June 1, 2026, also becoming a Senior Management Personnel. The board also approved a postal ballot for the appointment of Mr. Jain and Mr. Wenner.

In accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, Abbott India Ltd has announced the closure of the trading window for dealing in the Shares of the Company by the Designated Persons and their immediate relatives. The closure will begin from Wednesday, April 1, 2026, and will reopen after 48 hours from the declaration of the Annual Audited Financial Results of the Company for the financial year ended March 31, 2026.